FDA withdraws the proposal
Lastly, we intended to include RCTs to reduce the likelihood of recall and selection bias, but among four studies, three of them were open-label and one was single-blind clinical trials, which to some extent increased the risk of performance and detection bias
Compounded products offer customization and lower cost but less regulatory oversight
Cell Prolif 47(1):7280
News Release January 31, 2013 Use of CoQ10, Digestive Enzymes, Probiotics and B Vitamins on the Rise According to ConsumerLab.com Survey White Plains, New York February 1, 2013 A recent survey of over 10,000 people who take supplements shows that CoQ10, digestive enzymes, probiotics, and B vitamins are the four categories experiencing the most growth over the prior year